AIM letter to members and partners on the end of the COVID-19 Public Health Emergency.
AIM provides testimony to the House Appropriations Committee Subcommittee on Labor, Health & Human Services, Education, and Related Agencies regarding funding for Section 317 immunization programs.
On December 20, 2022, Congress released a final FY 2023 spending bill that includes a $31 million increase for the CDC’s Section 317 Immunization Program.
AIM provided comments on the Vaccines Federal Implementation Plan (VFIP). AIM commented on four key areas using lessons learned during the COVID-19 pandemic.
AIM provided public comment on the Proposed Changes and Proposed Measurement Retirements to the Adult Immunization Status Measure (AIS-E).
AIM and the National Association of School Nurses (NASN) are excited to share the NASN School Nurse January 2022 Special Supplement “School-Located Vaccination (SLV) Clinics in the Era of COVID-19.”
AIM Policy Consultant Brent Ewig, AIM Executive Director Claire Hannan, and ASTHO CEO Michael Fraser on COVID-19 vaccination and what lies ahead.
AIM joined with several other immunization stakeholders to urge Congress to include the Protecting Seniors Through Immunization Act in the Build Back Better package.
Good afternoon everyone, and thank you for all your support and hard work on behalf of the country. I want to quickly review…
Since the beginning of pandemic, immunization program managers have been working long days, nights, and weekends to address the many challenges of vaccinating the nation. The success and impact of this vaccine campaign are nothing short of miraculous.